De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial

Cardiovascular Revascularization Medicine · Published 2026-08-01 · DOI 10.1016/j.carrev.2026.07.022

Authors (25)

Francesco Costa, Giampiero Vizzari, Simone Zecchino, Mattia Galli, Claudio Montalto, Gabriele Carciotto, Giorgio Quadri, Rocco Vergallo, Fausto Castriota, Emmanuele Soraci, Alberto Magliarditi, Stefania Lo Giudice, Giustina Iuvara, Andrea Munafò, Federico Giannino, Francesco Pallante, Marco Franzino, Lucio Teresi, Raffaele Piccolo, Ferdinando Varbella, Giuseppe Musumeci, Gianluca Di Bella, Luis Ortega-Paz, Dominick J. Angiolillo, Antonio Micari

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Costa, F., Vizzari, G., Zecchino, S., et al. (2026). De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial. Cardiovascular Revascularization Medicine. https://doi.org/10.1016/j.carrev.2026.07.022

Related articles

• Age modifies the prognostic value of post-procedural high-sensitivity troponin T for mortality in patients with acute coronary syndrome: A registry study of 14,210 patients · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Long-term clinical prognostic utility of the SYNTAX score in all-comer patients with coronary artery disease who underwent percutaneous coronary intervention · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Expert perspectives on de-escalation of antiplatelet therapy – Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Routine echocardiography after left atrial appendage closure: The impact of patient selection and clinical triage on outcomes · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Angiography-derived physiology and biomechanics: The path toward a comprehensive plaque characterization reply · Cardiovascular Revascularization Medicine · 2026 · Same journal
• An assessment of the accuracy of a novel peripheral artery disease scoring system to identify obstructive coronary artery disease in patients with severe aortic stenosis · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCI · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Residual leaks after left atrial appendage occlusion · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Diagnostic and clinical management of non-obstructive myocardial ischemia in patients with long Covid-19 syndrome and new-onset chest pain: Design and rationale of the long Covid-19 INOCA trial · Cardiovascular Revascularization Medicine · 2026 · Same journal
• Device-specific failure patterns of guide catheter extensions in percutaneous coronary intervention: A contemporary MAUDE database analysis (2022–2025) · Cardiovascular Revascularization Medicine · 2026 · Same journal